Graft-Versus-Solid-Tumor Effect: From Hematopoietic Stem Cell Transplantation to Adoptive Cell Therapies

High-affinity CD16 integration into a CRISPR/Cas9-edited CD38 locus augments CD38-directed antitumor activity of primary human natural killer cells

(2022) Joseph Andrew Clara et al.   Journal for ImmunoTherapy of Cancer

Fecal microbiota transplant overcomes resistance to anti–PD-1 therapy in melanoma patients

(2021) Diwakar Davar et al.   SCIENCE

RNA-Seq Analysis Reveals CCR5 as a Key Target for CRISPR Gene Editing to Regulate In Vivo NK Cell Trafficking

(2021) Emily R. Levy et al.   Cancers

CD16xCD33 Bispecific Killer Cell Engager (BiKE) as potential immunotherapeutic in pediatric patients with AML and biphenotypic ALL

(2021) Sarah B. Reusing et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Interaction between microbiota and immunity in health and disease

(2020) Danping Zheng et al.   CELL RESEARCH

Editorial: Understanding Gamma Delta T Cell Multifunctionality - Towards Immunotherapeutic Applications

(2020) Kenth Gustafsson et al.   Frontiers in Immunology

Adoptive cell therapy in combination with checkpoint inhibitors in ovarian cancer

(2020) Anders Handrup Kverneland et al.   Oncotarget

Solid Tumor–Induced Immune Regulation Alters the GvHD/GvT Paradigm after Allogenic Bone Marrow Transplantation

(2019) Nana Dang et al.   CANCER RESEARCH

Manipulating the tumor microenvironment by adoptive cell transfer of CAR T-cells

(2018) Kavitha Gowrishankar et al.   MAMMALIAN GENOME

The commensal microbiome is associated with anti–PD-1 efficacy in metastatic melanoma patients

(2018) Vyara Matson et al.   SCIENCE

NK Cells Mediate a Crucial Graft-versus-Leukemia Effect in Haploidentical-HSCT to Cure High-Risk Acute Leukemia

(2018) Franco Locatelli et al.   TRENDS IN IMMUNOLOGY

Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients

(2017) V. Gopalakrishnan et al.   SCIENCE

Detection of an Immunogenic HERV-E Envelope with Selective Expression in Clear Cell Kidney Cancer

(2016) Elena Cherkasova et al.   CANCER RESEARCH

Functional Reconstitution of Natural Killer Cells in Allogeneic Hematopoietic Stem Cell Transplantation

(2016) Md Ashik Ullah et al.   Frontiers in Immunology

UGT2B17 minor histocompatibility mismatch and clinical outcome after HLA-identical sibling donor stem cell transplantation

(2015) N Santos et al.   BONE MARROW TRANSPLANTATION

Sensitivity of hematological malignancies to graft-versus-host effects: an EBMT megafile analysis

(2014) M Stern et al.   LEUKEMIA

Allele frequency net 2015 update: new features for HLA epitopes, KIR and disease and HLA adverse drug reaction associations

(2014) Faviel F. González-Galarza et al.   NUCLEIC ACIDS RESEARCH

The Role of Dendritic Cells in Graft-Versus-Tumor Effect

(2014) Tomomi Toubai et al.   Frontiers in Immunology

Host-derived CD8+ dendritic cells are required for induction of optimal graft-versus-tumor responses after experimental allogeneic bone marrow transplantation

(2013) T. Toubai et al.   BLOOD

Expansion of CD56-Negative, CD16-Positive, KIR-Expressing Natural Killer Cells after T Cell-Depleted Haploidentical Hematopoietic Stem Cell Transplantation

(2011) Claudia De Angelis et al.   ACTA HAEMATOLOGICA

Type I interferon is selectively required by dendritic cells for immune rejection of tumors

(2011) Mark S. Diamond et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Inactivation of the von Hippel–Lindau tumor suppressor leads to selective expression of a human endogenous retrovirus in kidney cancer

(2011) E Cherkasova et al.   ONCOGENE

A Polymorphism in the Splice Donor Site of ZNF419 Results in the Novel Renal Cell Carcinoma-Associated Minor Histocompatibility Antigen ZAPHIR

(2011) Kelly Broen et al.   PLoS One

Allogeneic hematopoietic stem cell transplantation in ovarian cancer-the EBMT experience

(2010) Jacques-Olivier Bay et al.   INTERNATIONAL JOURNAL OF CANCER

Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recognizing ERBB2

(2010) Richard A Morgan et al.   MOLECULAR THERAPY

Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation in Metastatic Colorectal Cancer as a Novel Adoptive Cell Therapy Approach. The European Group for Blood and Marrow Transplantation Experience

(2009) Massimo Aglietta et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Breaking tolerance to self, circulating natural killer cells expressing inhibitory KIR for non-self HLA exhibit effector function after T cell-depleted allogeneic hematopoietic cell transplantation

(2009) J. Yu et al.   BLOOD

KIR and HLA Genotypes Are Associated with Disease Progression and Survival following Autologous Hematopoietic Stem Cell Transplantation for High-Risk Neuroblastoma

(2009) J. M. Venstrom et al.   CLINICAL CANCER RESEARCH

KIR-HLA receptor-ligand mismatch associated with a graft-versus-tumor effect in haploidentical stem cell transplantation for pediatric metastatic solid tumors

(2009) Antonio Pérez-Martínez et al.   PEDIATRIC BLOOD & CANCER

C19orf48 Encodes a Minor Histocompatibility Antigen Recognized by CD8+ Cytotoxic T Cells from Renal Cell Carcinoma Patients

(2008) S. S. Tykodi et al.   CLINICAL CANCER RESEARCH

Regression of human kidney cancer following allogeneic stem cell transplantation is associated with recognition of an HERV-E antigen by T cells

(2008) Yoshiyuki Takahashi et al.   JOURNAL OF CLINICAL INVESTIGATION

Genetic Variation in an Individual Human Exome

(2008) Pauline C. Ng et al.   PLoS Genetics